Works matching IS 01145916 AND DT 2025 AND VI 48 AND IP 3

Results: 10

Pharmacovigilance in the Community: A Special-Interest Group of the International Society of Pharmacovigilance: Pharmacovigilance in the Community: M. A. Elhawary et al.

Published in:

Drug Safety, 2025, v. 48, n. 3, p. 203, doi. 10.1007/s40264-024-01513-6

By:

Elhawary, Mohamed A.;
Noss, Rebecca;
Alj, Loubna;
Younus, Manal;
Alkhakany, Mayada;
Rostom, Hadir;
Caro-Rojas, Angela;
Alshammari, Thamir M.

Publication type:

Article

Principles and Practice of Pharmacovigilance and Drug Safety: Jimmy Jose, Anthony R. Cox, Vibhu Paudyal, editors. Springer, 2024. Hardcover ISBN 978-3-031-51088-5, Softcover ISBN 978-3-031-51091-5, eBook ISBN 978-3-031-51089-2: Principles and Practice of Pharmacovigilance and Drug Safety: I. W. Boyd

Published in:

Drug Safety, 2025, v. 48, n. 3, p. 311, doi. 10.1007/s40264-024-01508-3

By:

Boyd, Ian W.

Publication type:

Article

Advances in Drug Safety: Highlights from the 23rd Annual Meeting of the International Society of Pharmacovigilance: Highlights from the 23rd Annual Meeting of the International Society of Pharmacovigilance: O. Aimer et al.

Published in:

Drug Safety, 2025, v. 48, n. 3, p. 305, doi. 10.1007/s40264-024-01507-4

By:

Aimer, Omar;
Salas, Maribel;
Hammad, Tarek A;
Mouchantaf, Rania;
Ilic, Katarina;
Gossell-Williams, Maxine;
Mehta, Ushma;
Platt, Robert W.;
Carleton, Bruce

Publication type:

Article

Performance and Reproducibility of Large Language Models in Named Entity Recognition: Considerations for the Use in Controlled Environments: LLM Performance and Reproducibility in Named Entity Recognition in Controlled Environments: J. Dietrich, A. Hollstein

Published in:

Drug Safety, 2025, v. 48, n. 3, p. 287, doi. 10.1007/s40264-024-01499-1

By:

Dietrich, Jürgen;
Hollstein, André

Publication type:

Article

Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS): Post-licensure Safety of 20-Valent Pneumococcal Conjugate Vaccine in VAERS: M. Oliveira et al.

Published in:

Drug Safety, 2025, v. 48, n. 3, p. 279, doi. 10.1007/s40264-024-01498-2

By:

Oliveira, Mayra;
Marquez, Paige;
Ennulat, Carol;
Blanc, Phillip;
Welsh, Kerry;
Nair, Narayan;
Taminato, Monica;
Moro, Pedro L.

Publication type:

Article

Prenatal Exposure to Proton Pump Inhibitors and Risk of Serious Infections in Offspring During the First Year of Life: A Nationwide Cohort Study: Prenatal PPIs Exposure and Serious Infections in Infants: M. Tisseyre et al.

Published in:

Drug Safety, 2025, v. 48, n. 3, p. 265, doi. 10.1007/s40264-024-01496-4

By:

Tisseyre, Mylène;
Collier, Mathis;
Beeker, Nathanaël;
Kaguelidou, Florentia;
Treluyer, Jean-Marc;
Chouchana, Laurent

Publication type:

Article

Early Detection of Hearing Impairment Signals Post-mRNA COVID-19 Vaccination: A Disproportionality Analysis Study on French Pharmacovigilance Database: Early Detection of Hearing Impairment Signals Post-mRNA COVID-19 Vaccination: D. Boulefaa et al.

Published in:

Drug Safety, 2025, v. 48, n. 3, p. 251, doi. 10.1007/s40264-024-01495-5

By:

Boulefaa, Dalil;
Bagheri, Haleh;
Salvo, Francesco;
Rabier, Marie-Blanche;
Geniaux, Hélène;
Lepelley, Marion;
Rocher, Fanny;
Mahe, Julien;
Grandvillemuin, Aurélie;
Thai-Van, Hung

Publication type:

Article

Antiretroviral Use for HIV Prevention During Pregnancy: The Need to Strengthen Regulatory and Surveillance Systems in Africa: HIV Prevention During Pregnancy and Regulatory and Surveillance Systems in Africa : R. Schaefer et al.

Published in:

Drug Safety, 2025, v. 48, n. 3, p. 209, doi. 10.1007/s40264-024-01494-6

By:

Schaefer, Robin;
Donaldson, L.;
Chigome, A.;
Escudeiro dos Santos, M.;
Lamprianou, S.;
Ndembi, N.;
Nwokike, J. I.;
Nyambayo, P.;
Palmi, V.;
Renaud, F.;
Gonzalez Tome, M.;
Miller, V.

Publication type:

Article

Empowering African Expertise: Enhancing Safety Data Integration and Signal Detection for COVID-19 Vaccines Through the African Union Smart Safety Surveillance Joint Signal Management Group: Joint Signal Management Group Signal Detection for COVID-19 Vaccines: V. P. Nambasa et al

Published in:

Drug Safety, 2025, v. 48, n. 3, p. 233, doi. 10.1007/s40264-024-01493-7

By:

Nambasa, Victoria Prudence;
Gunter, Hannah May;
Adeyemo, Modupe Bamidele;
Bhawaneedin, Neetesh Yanish;
Blockman, Marc;
Sabblah, George Tsey;
Gyapong, John Owusu;
Guantai, Eric Muriithi;
Abebe, Tamrat;
Abebe, Workeabeba;
Lawson, Henry Jeremy;
Leburu, Mercedes Chawada;
Mohammed, Abdullahi;
Amponsa-Achiano, Kwame;
Matlala, Mafora Florah;
Elemuwa, Uchenna Geraldine;
Mogtari, Hudu;
Nyarko, Alexander Kwadwo;
Schönfeldt, Marione;
Kamupira, Mercy

Publication type:

Article

Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database: Detection of Persistent Gustatory, Olfactory and Auditory AEs to Antibiotics in EudraVigilance: S. Ferraro et al

Published in:

Drug Safety, 2025, v. 48, n. 3, p. 217, doi. 10.1007/s40264-024-01491-9

By:

Ferraro, Sara;
Cappello, Emiliano;
Fornili, Marco;
Convertino, Irma;
Bonaso, Marco;
Lucenteforte, Ersilia;
Tuccori, Marco

Publication type:

Article